By Denny Jacob
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.
Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply.
"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business," said Chief Executive Simon Campion.
The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 11, 2025 09:04 ET (14:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。